pharma news today obesity drugs glp-1 october 2025 Drugmakers are racing to find the next Wegovy. These trials are ones to watch Obesity drugs could fuel the
Description
Mounjaro is a new medication for managing blood sugar in people with type 2 diabetes
To address these gaps, we introduce an evidence-informed nutrition framework to guide health care professionals in assessment, diagnosis, intervention, and monitoring during GLP1 therapy
Here, experts weigh in with mitigation strategies
Latest review of the Tirzepatide dual receptor agonist GLP-1/GIP, summarizing five clinical trials in type 2-diabetic subjects.
Women prescribed a GLP-1 receptor agonist up to 2 years before conception were less likely to develop hypertensive disorders of pregnancy, gestational diabetes, have a preterm birth or cesarean delivery, researchers reported.“Relatively little is known how preconception GLP-1 receptor agonist use may impact pregnancy outcomes,&rdquo
Whether you're on a GLP-1 medication and want complementary support, or you're taking the natural route entirely, this patch was made for you
